On 7/15/24, Trxade Health Inc (NASDAQ: MEDS) stock enjoyed a major increase of 23.9%, closing at $20.99. NORMAL trading volume accompanied the advance. The stock has been exceptionally strong relative to the market over the last nine months and has risen 24.0% during the last week.
Current PriceTarget Research Rating
MEDS is expected to continue to be a modest Value Eraser reflecting capital returns that are forecasted to be below the cost of capital.
Trxade Health has a current Value Trend Rating of C (Low Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Trxade Health has a very low Appreciation Score of 1 but a very high Power Rating of 91, resulting in the Low Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment